3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors

Details for Australian Patent Application No. 2004305079 (hide)

Owner Incyte Corporation

Inventors Xue, Chu-Biao; Zhang, Yingxin; Robinson, Darius J.; Han, Amy Qi; Zheng, Changsheng; Wang, Anlai; Metcalf, Brian

Agent Allens Arthur Robinson

Pub. Number AU-B-2004305079

PCT Pub. Number WO2005/060665

Priority 60/531,270 18.12.03 US

Filing date 16 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 12 May 2011

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/060665 Priority application(s): WO2005/060665

12 May 2011 Application Accepted

  Published as AU-B-2004305079

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305087-Intravenous medication harm index system

2004305075-Methods and materiale for assessing prostate cancer therapies